Virpax Pharmaceuticals, Inc. Common Stock (VRPX)

VRPX was delisted on the 3rd of April, 2025.

• Market cap: $832K
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Employees: 2